Quince Therapeutics, Inc. (IRLA): 8-K filed Oct 6, 2026

Form type

8-K

Filing date

Oct 6, 2026

Accession number

0001193125-26-415730

Filer

Quince Therapeutics, Inc. (CIK 1662774)